psych_news Guest User 26/7/22 psych_news Guest User 26/7/22 The high-stakes race to engineer new psychedelic drugs Read More psych_news Guest User 19/7/22 psych_news Guest User 19/7/22 Psychedelics provide new frontier for venture funding, but nuances prevail Read More psych_news Guest User 15/7/22 psych_news Guest User 15/7/22 Taking the magic out of magic mushrooms Read More psych_news Guest User 23/6/22 psych_news Guest User 23/6/22 MDMA and psilocybin are being trialed to enhance therapy for veterans Read More psych_news Guest User 6/6/22 psych_news Guest User 6/6/22 How psychedelic drugs might treat depression Read More psych_news Guest User 3/6/22 psych_news Guest User 3/6/22 New study to evaluate psilocybin's therapeutic potential on autistic adults Read More psych_news Guest User 31/5/22 psych_news Guest User 31/5/22 Can you take the trip out of psychedelics and still treat depression? Read More psych_news Guest User 24/5/22 psych_news Guest User 24/5/22 $2.7M grant from NIDA to find to develop non-hallucinogenic psychedelic analogues for substance use disorders Read More psych_news Guest User 17/5/22 psych_news Guest User 17/5/22 CSIRO starts work on medicinal psychedelics Read More psych_news Guest User 16/5/22 psych_news Guest User 16/5/22 Inside the Dispute Over a High-Profile Psychedelic Study Read More psych_news Guest User 11/5/22 psych_news Guest User 11/5/22 MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders Read More psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 Europe’s first psychedelic drug trial firm to open in London Read More psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD Read More psych_news Guest User 10/4/22 psych_news Guest User 10/4/22 Psilocybin Rewires the Brain for People with Depression Read More psych_news Guest User 23/3/22 psych_news Guest User 23/3/22 Why microdosing is gaining momentum in Australia Read More psych_news Guest User 10/3/22 psych_news Guest User 10/3/22 Johns Hopkins, Yale, and NYU are teaming up to tackle a key bottleneck that will arise as psychedelics come to market Read More psych_news Dilara Bahceci 19/2/22 psych_news Dilara Bahceci 19/2/22 Psychoactive ingredient in ‘magic’ mushrooms may treat depression for much longer than traditional antidepressants when combined with therapy Read More psych_news Guest User 18/2/22 psych_news Guest User 18/2/22 At Harvard, Psychedelic Drugs' Tentative Renaissance Read More psych_news Dilara Bahceci 27/1/22 psych_news Dilara Bahceci 27/1/22 How AI could unlock the medical potential of psychedelics Read More psych_news Josh Ismin 26/1/22 psych_news Josh Ismin 26/1/22 No hallucinations? LSD relatives appear to treat depression in mice, without obvious side effects Read More Older Posts
psych_news Guest User 26/7/22 psych_news Guest User 26/7/22 The high-stakes race to engineer new psychedelic drugs Read More
psych_news Guest User 19/7/22 psych_news Guest User 19/7/22 Psychedelics provide new frontier for venture funding, but nuances prevail Read More
psych_news Guest User 15/7/22 psych_news Guest User 15/7/22 Taking the magic out of magic mushrooms Read More
psych_news Guest User 23/6/22 psych_news Guest User 23/6/22 MDMA and psilocybin are being trialed to enhance therapy for veterans Read More
psych_news Guest User 6/6/22 psych_news Guest User 6/6/22 How psychedelic drugs might treat depression Read More
psych_news Guest User 3/6/22 psych_news Guest User 3/6/22 New study to evaluate psilocybin's therapeutic potential on autistic adults Read More
psych_news Guest User 31/5/22 psych_news Guest User 31/5/22 Can you take the trip out of psychedelics and still treat depression? Read More
psych_news Guest User 24/5/22 psych_news Guest User 24/5/22 $2.7M grant from NIDA to find to develop non-hallucinogenic psychedelic analogues for substance use disorders Read More
psych_news Guest User 17/5/22 psych_news Guest User 17/5/22 CSIRO starts work on medicinal psychedelics Read More
psych_news Guest User 16/5/22 psych_news Guest User 16/5/22 Inside the Dispute Over a High-Profile Psychedelic Study Read More
psych_news Guest User 11/5/22 psych_news Guest User 11/5/22 MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders Read More
psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 Europe’s first psychedelic drug trial firm to open in London Read More
psych_news Guest User 9/5/22 psych_news Guest User 9/5/22 MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD Read More
psych_news Guest User 10/4/22 psych_news Guest User 10/4/22 Psilocybin Rewires the Brain for People with Depression Read More
psych_news Guest User 23/3/22 psych_news Guest User 23/3/22 Why microdosing is gaining momentum in Australia Read More
psych_news Guest User 10/3/22 psych_news Guest User 10/3/22 Johns Hopkins, Yale, and NYU are teaming up to tackle a key bottleneck that will arise as psychedelics come to market Read More
psych_news Dilara Bahceci 19/2/22 psych_news Dilara Bahceci 19/2/22 Psychoactive ingredient in ‘magic’ mushrooms may treat depression for much longer than traditional antidepressants when combined with therapy Read More
psych_news Guest User 18/2/22 psych_news Guest User 18/2/22 At Harvard, Psychedelic Drugs' Tentative Renaissance Read More
psych_news Dilara Bahceci 27/1/22 psych_news Dilara Bahceci 27/1/22 How AI could unlock the medical potential of psychedelics Read More
psych_news Josh Ismin 26/1/22 psych_news Josh Ismin 26/1/22 No hallucinations? LSD relatives appear to treat depression in mice, without obvious side effects Read More
